330 related articles for article (PubMed ID: 25670083)
1. Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors.
Wegert J; Ishaque N; Vardapour R; Geörg C; Gu Z; Bieg M; Ziegler B; Bausenwein S; Nourkami N; Ludwig N; Keller A; Grimm C; Kneitz S; Williams RD; Chagtai T; Pritchard-Jones K; van Sluis P; Volckmann R; Koster J; Versteeg R; Acha T; O'Sullivan MJ; Bode PK; Niggli F; Tytgat GA; van Tinteren H; van den Heuvel-Eibrink MM; Meese E; Vokuhl C; Leuschner I; Graf N; Eils R; Pfister SM; Kool M; Gessler M
Cancer Cell; 2015 Feb; 27(2):298-311. PubMed ID: 25670083
[TBL] [Abstract][Full Text] [Related]
2. Recurrent DGCR8, DROSHA, and SIX homeodomain mutations in favorable histology Wilms tumors.
Walz AL; Ooms A; Gadd S; Gerhard DS; Smith MA; Guidry Auvil JM; Meerzaman D; Chen QR; Hsu CH; Yan C; Nguyen C; Hu Y; Bowlby R; Brooks D; Ma Y; Mungall AJ; Moore RA; Schein J; Marra MA; Huff V; Dome JS; Chi YY; Mullighan CG; Ma J; Wheeler DA; Hampton OA; Jafari N; Ross N; Gastier-Foster JM; Perlman EJ
Cancer Cell; 2015 Feb; 27(2):286-97. PubMed ID: 25670082
[TBL] [Abstract][Full Text] [Related]
3. Chromosomal anomalies at 1q, 3, 16q, and mutations of SIX1 and DROSHA genes underlie Wilms tumor recurrences.
Spreafico F; Ciceri S; Gamba B; Torri F; Terenziani M; Collini P; Macciardi F; Radice P; Perotti D
Oncotarget; 2016 Feb; 7(8):8908-15. PubMed ID: 26802027
[TBL] [Abstract][Full Text] [Related]
4. The DGCR8 E518K mutation found in Wilms tumors leads to a partial miRNA processing defect that alters gene expression patterns and biological processes.
Vardapour R; Kehl T; Kneitz S; Ludwig N; Meese E; Lenhof HP; Gessler M
Carcinogenesis; 2022 Mar; 43(2):82-93. PubMed ID: 34919667
[TBL] [Abstract][Full Text] [Related]
5. Altered binding affinity of SIX1-Q177R correlates with enhanced WNT5A and WNT pathway effector expression in Wilms tumor.
Stevenson MJ; Phanor SK; Patel U; Gisselbrecht SS; Bulyk ML; O'Brien LL
Dis Model Mech; 2023 Nov; 16(11):. PubMed ID: 37815464
[TBL] [Abstract][Full Text] [Related]
6. Recurrent somatic mutation in DROSHA induces microRNA profile changes in Wilms tumour.
Torrezan GT; Ferreira EN; Nakahata AM; Barros BD; Castro MT; Correa BR; Krepischi AC; Olivieri EH; Cunha IW; Tabori U; Grundy PE; Costa CM; de Camargo B; Galante PA; Carraro DM
Nat Commun; 2014 Jun; 5():4039. PubMed ID: 24909261
[TBL] [Abstract][Full Text] [Related]
7. Loss or oncogenic mutation of DROSHA impairs kidney development and function, but is not sufficient for Wilms tumor formation.
Kruber P; Angay O; Winkler A; Bösl MR; Kneitz S; Heinze KG; Gessler M
Int J Cancer; 2019 Mar; 144(6):1391-1400. PubMed ID: 30367465
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutations in DROSHA and DICER1 impair microRNA biogenesis through distinct mechanisms in Wilms tumours.
Rakheja D; Chen KS; Liu Y; Shukla AA; Schmid V; Chang TC; Khokhar S; Wickiser JE; Karandikar NJ; Malter JS; Mendell JT; Amatruda JF
Nat Commun; 2014 Sep; 2():4802. PubMed ID: 25190313
[TBL] [Abstract][Full Text] [Related]
9. Analysis of the mutational status of SIX1/2 and microRNA processing genes in paired primary and relapsed Wilms tumors and association with relapse.
Ciceri S; Montalvão-de-Azevedo R; Tajbakhsh A; Bertolotti A; Spagnuolo RD; Boschetti L; Capasso M; D'Angelo P; Serra A; Diomedi-Camassei F; Meli M; Nantron M; Quarello P; Buccoliero AM; Tamburini A; Ciniselli CM; Verderio P; Collini P; Radice P; Spreafico F; Perotti D
Cancer Gene Ther; 2021 Sep; 28(9):1016-1024. PubMed ID: 33281191
[TBL] [Abstract][Full Text] [Related]
10. A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor.
Gadd S; Huff V; Walz AL; Ooms AHAG; Armstrong AE; Gerhard DS; Smith MA; Auvil JMG; Meerzaman D; Chen QR; Hsu CH; Yan C; Nguyen C; Hu Y; Hermida LC; Davidsen T; Gesuwan P; Ma Y; Zong Z; Mungall AJ; Moore RA; Marra MA; Dome JS; Mullighan CG; Ma J; Wheeler DA; Hampton OA; Ross N; Gastier-Foster JM; Arold ST; Perlman EJ
Nat Genet; 2017 Oct; 49(10):1487-1494. PubMed ID: 28825729
[TBL] [Abstract][Full Text] [Related]
11. SIX1 protein expression selectively identifies blastemal elements in Wilms tumor.
Sehic D; Karlsson J; Sandstedt B; Gisselsson D
Pediatr Blood Cancer; 2012 Jul; 59(1):62-8. PubMed ID: 22180226
[TBL] [Abstract][Full Text] [Related]
12. A heterotrimer model of the complete Microprocessor complex revealed by single-molecule subunit counting.
Herbert KM; Sarkar SK; Mills M; Delgado De la Herran HC; Neuman KC; Steitz JA
RNA; 2016 Feb; 22(2):175-83. PubMed ID: 26683315
[TBL] [Abstract][Full Text] [Related]
13. Post-transcriptional control of DGCR8 expression by the Microprocessor.
Triboulet R; Chang HM; Lapierre RJ; Gregory RI
RNA; 2009 Jun; 15(6):1005-11. PubMed ID: 19383765
[TBL] [Abstract][Full Text] [Related]
14. Posttranscriptional crossregulation between Drosha and DGCR8.
Han J; Pedersen JS; Kwon SC; Belair CD; Kim YK; Yeom KH; Yang WY; Haussler D; Blelloch R; Kim VN
Cell; 2009 Jan; 136(1):75-84. PubMed ID: 19135890
[TBL] [Abstract][Full Text] [Related]
15. Functional Anatomy of the Human Microprocessor.
Nguyen TA; Jo MH; Choi YG; Park J; Kwon SC; Hohng S; Kim VN; Woo JS
Cell; 2015 Jun; 161(6):1374-87. PubMed ID: 26027739
[TBL] [Abstract][Full Text] [Related]
16. Association of miRNA biosynthesis genes
Wen J; Lv Z; Ding H; Fang X; Sun M
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654164
[TBL] [Abstract][Full Text] [Related]
17. The role of TCF3 as potential master regulator in blastemal Wilms tumors.
Kehl T; Schneider L; Kattler K; Stöckel D; Wegert J; Gerstner N; Ludwig N; Distler U; Tenzer S; Gessler M; Walter J; Keller A; Graf N; Meese E; Lenhof HP
Int J Cancer; 2019 Mar; 144(6):1432-1443. PubMed ID: 30155889
[TBL] [Abstract][Full Text] [Related]
18. Quantitative RT-PCR-based miRNA profiling of blastemal Wilms' tumors from formalin-fixed paraffin-embedded samples.
Buglyó G; Magyar Z; Romicsné Görbe É; Bánusz R; Csóka M; Micsik T; Berki Z; Varga P; Sápi Z; Nagy B
J Biotechnol; 2019 Jun; 298():11-15. PubMed ID: 30959135
[TBL] [Abstract][Full Text] [Related]
19. Genomic Clustering Facilitates Nuclear Processing of Suboptimal Pri-miRNA Loci.
Shang R; Baek SC; Kim K; Kim B; Kim VN; Lai EC
Mol Cell; 2020 Apr; 78(2):303-316.e4. PubMed ID: 32302542
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of microRNA processing enzymes Drosha and Dicer in gestational diabetes mellitus.
Rahimi G; Jafari N; Khodabakhsh M; Shirzad Z; Dogaheh HP
Gynecol Endocrinol; 2015 Feb; 31(2):156-9. PubMed ID: 25295740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
